Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Top Cited Papers
- 31 January 2010
- journal article
- editorial
- Published by Elsevier BV in The Lancet Neurology
- Vol. 9 (1), 119-128
- https://doi.org/10.1016/s1474-4422(09)70299-6
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer’s diseaseActa Neuropathologica, 2009
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without DementiaNeuron, 2009
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal FluidBiological Psychiatry, 2009
- Preclinical Evidence of Alzheimer ChangesArchives of Neurology, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderlyAnnals of Neurology, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- β‐amyloid burden is not associated with rates of brain atrophyAnnals of Neurology, 2008
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991